Cigna Investments’s Novanta NOVT Stock Holding History

Cigna Investments’s Portfolio NOVT Stock Details NOVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-25,139	Closed	-$528K	–	764
2016 Q4	$528K	Buy	+25,139	New	+$479K	0.06%	384

Other funds holding NOVT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cigna Investments's NOVT Position: Q1 2017 in Review

Cigna Investments sold out of Novanta (NOVT) in Q1 2017, closing a stake of 25,139 shares — an estimated $528K sold.

Cigna Investments first reported a position in NOVT in Q4 2016 and held it in 1 quarter. The position peaked at $528K in Q4 2016. 115 funds tracked by Wall St. Rank hold NOVT as of Q1 2017.

Cigna Investments reported no remaining Novanta position as of Q1 2017 after selling out during the quarter.
Cigna Investments sold 25,139 Novanta shares in Q1 2017, an estimated $528K.
Cigna Investments first reported a position in Novanta in Q4 2016 and held it in 1 quarter.
Cigna Investments's Novanta position peaked at $528K in Q4 2016.
115 funds tracked by Wall St. Rank held Novanta as of Q1 2017.

Based on Cigna Investments's 13F filing for Q1 2017, filed 15 May 2017.